Technical Trends Shift to Mildly Bearish
The primary catalyst for the rating upgrade stems from a notable change in the technical outlook. The company’s technical grade has improved from a bearish stance to mildly bearish, signalling a tentative shift in market sentiment. Weekly MACD readings have turned mildly bullish, contrasting with a still bearish monthly MACD, indicating short-term momentum is gaining strength while longer-term trends remain cautious.
Additional technical indicators present a mixed picture: weekly Bollinger Bands suggest bullish momentum, whereas monthly bands remain mildly bearish. The daily moving averages continue to show mild bearishness, reflecting some resistance at current price levels. The KST (Know Sure Thing) indicator aligns with the weekly mildly bullish trend but remains bearish on the monthly scale. Notably, the Dow Theory shows no clear trend on both weekly and monthly timeframes, highlighting uncertainty in broader market direction for the stock.
These technical nuances have contributed to the stock’s recent price jump to ₹35.46 from a previous close of ₹29.55, with a 52-week range between ₹28.00 and ₹47.90. The short-term price action has outperformed the Sensex, with a 1-week return of 18.00% compared to the benchmark’s -0.21%, and a 1-month return of 13.73% versus Sensex’s -8.40%. However, longer-term returns remain subdued, with a 1-year return of -10.23% against Sensex’s 1.86% and a 3-year return of -18.91% compared to Sensex’s robust 32.27%.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Valuation Upgraded from Very Attractive to Attractive
Alongside technical improvements, valuation metrics have also contributed to the upgrade. Natraj Proteins’ valuation grade has shifted from very attractive to attractive, reflecting a modest re-rating in market perception. The company currently trades at a price-to-earnings (PE) ratio of 10.30, which is competitive within the refined oil and vanaspati industry. Its price-to-book value stands at a low 0.45, indicating the stock is priced below its net asset value, a factor that appeals to value investors.
Enterprise value multiples further support this valuation stance: EV to EBIT is 9.76, EV to EBITDA is 8.88, and EV to capital employed is a notably low 0.68. These figures suggest the company is trading at a discount relative to its earnings and asset base. The PEG ratio of 0.06 is particularly compelling, signalling that the stock’s price is low relative to its earnings growth potential, despite recent underperformance.
Return on capital employed (ROCE) remains modest at 1.03%, while return on equity (ROE) is 4.40%, underscoring limited profitability. However, the attractive valuation multiples may offer a margin of safety for investors willing to tolerate the company’s fundamental challenges.
Financial Trend Remains Weak Despite Recent Quarterly Improvement
Despite the upgrade, the company’s financial trend continues to weigh on its rating. Over the past five years, Natraj Proteins has experienced a negative compound annual growth rate (CAGR) of -5.06% in net sales, reflecting a contraction in its core business. The average return on equity of 6.97% further highlights the company’s low profitability per unit of shareholder funds.
Moreover, the stock has consistently underperformed the BSE500 benchmark over the last three years, with a 1-year return of -10.23% compared to the benchmark’s positive 1.86%. This persistent underperformance raises concerns about the company’s ability to generate sustainable shareholder value in the medium to long term.
However, there are signs of recent operational improvement. The company reported positive results in December 2025 after two consecutive quarters of negative performance. Quarterly PBDIT reached a high of ₹3.54 crores, with operating profit to net sales at 12.30%, the highest in recent periods. Profit before tax excluding other income also peaked at ₹2.86 crores, signalling a potential turnaround in profitability.
Quality Parameters and Shareholding Structure
Quality metrics remain a concern for investors. The company’s micro-cap status and weak long-term fundamentals limit its appeal to risk-averse investors. The majority shareholding is held by non-institutional investors, which may impact liquidity and governance perceptions. While the recent financial and technical improvements are encouraging, the company’s overall quality grade remains low, consistent with its Sell rating.
Holding Natraj Proteins Ltd from Edible Oil? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Comparative Industry Context and Peer Valuation
Within the refined oil and vanaspati industry, Natraj Proteins’ valuation multiples are attractive but not the most compelling. Peers such as BCL Industries and KSE trade at lower PE ratios of 6.95 and 5.10 respectively, with very attractive valuation grades. Other companies like AVT Natural Products and Kriti Nutrients also maintain attractive valuations but with stronger growth prospects and profitability metrics.
This comparative context suggests that while Natraj Proteins offers value, investors may find superior risk-reward profiles in other industry players. The company’s PEG ratio of 0.06 is notably lower than peers, indicating undervaluation relative to growth, but this must be balanced against its weak financial trends and quality concerns.
Outlook and Investment Implications
The upgrade to a Sell rating from Strong Sell reflects a cautious optimism driven by improved technical signals and a more favourable valuation profile. The stock’s recent price appreciation and positive quarterly results hint at a possible turnaround, but the company’s weak long-term fundamentals and underperformance relative to benchmarks temper enthusiasm.
Investors should weigh the attractive entry valuation against the risks posed by low profitability, negative sales growth, and limited institutional backing. The mildly bullish technical indicators may offer short-term trading opportunities, but the overall investment thesis remains conservative given the company’s micro-cap status and sector challenges.
In summary, Natraj Proteins Ltd’s rating upgrade is a reflection of evolving market dynamics and valuation reassessment rather than a fundamental transformation. Investors seeking exposure to the edible oil sector should consider the company’s position within the broader industry landscape and remain vigilant to ongoing financial and operational developments.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
